Dewdney et al. showed that expression of RSK4 is reduced by hypermethylation in colon, breast, and kidney cancer, as well as in endometrial cancer, but the tumor inhibitory action of RSK4 in the endometrium is unclear [8]. This evidence concerns the gene RPS6KA6 and endometrial cancer.